IPO Comments to U.S. Copyright Office on Proposed New Fee Schedule
IPO Comments to U.S. Copyright Office on Proposed New Fee [...]
IPO Comments to JPO re: Design Registration System Issues
IPO Comments to JPO re: Design Registration System Issues
IPO Comments on USPTO Proposed Patent Fee Schedule
IPO Comments on USPTO Proposed Patent Fee Schedule
IP Associations Letter to House and Senate Judiciary Committees re: Presumption of Irreparable Harm Under Lanham Act
IP Associations Letter to House and Senate Judiciary Committees re: [...]
IPO Amicus Brief in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., et. al, 17-1229
IPO Amicus Brief in Helsinn Healthcare S.A. v. Teva Pharmaceuticals [...]
IPO Comments to China’s Ministry of Commerce on Revised Draft Catalogues of Technologies Prohibited and Restricted from Import and Export
IPO Comments to China’s Ministry of Commerce on Revised Draft [...]
IPO Letter to WIPO with Questions and Information re: (1) Requirement for a Link Between GUIs, Icons, Typeface/Type Font Designs and the Article or Product and (2) Methods Allowed by Offices for Representation of Animated Designs
IPO Letter to WIPO with Questions and Information re: (1) [...]
IPO Comments to USPTO re: Proposal to Change Claim Construction Standard for IPR, PGR, and CBM Proceedings
IPO Comments to USPTO re: Proposal to Change Claim Construction [...]
IPO’s Comments to NTIA on International Internet Policy Priorities
IPO’s Comments to NTIA on International Internet Policy Priorities
IPO’s Comments to China’s Supreme People’s Court on Provisions on Several Issues Concerning the Trial of Administrative Cases Involving the Granting and Affirmation of Patent Right
IPO’s Comments to China’s Supreme People’s Court on Provisions on [...]